A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Sajjad Desai, K. Anil, Anirudha Vyankatesh Potey, Y. Sindhu, Silvia Grappi, Giulia Lapini, Satyaprasad Manney, Parikshit Tyagi, Emanuele Montomoli, Cyrus S. Poonawalla, Prasad S. Kulkarni
Format:	Article
Sprog:	English
Udgivet:	Nature Portfolio 2022-12-01
Serier:	npj Vaccines
Online adgang:	https://doi.org/10.1038/s41541-022-00595-6

Lignende værker

A cross-sectional study to assess the incompatible dietary behavior of patients suffering from skin diseases: A pilot study
af: Meghana Kulkarni, et al.
Udgivet: (2016-04-01)

Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
af: Elena Gianchecchi, et al.
Udgivet: (2022-02-01)

Electron transport chain capacity expands yellow fever vaccine immunogenicity
af: Darren ZL Mok, et al.
Udgivet: (2024-05-01)

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease
af: Jesiree Iglésias Quadros Distenhreft, et al.
Udgivet: (2024-08-01)

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
af: Ji Ma, et al.
Udgivet: (2021-01-01)

Current challenges and improvements in assessing the immunogenicity of bacterial vaccines
af: Giulia Fantoni, et al.
Udgivet: (2024-07-01)

Immunogenicity and Protective Efficacy of Aerosolized Live-Attenuated Yellow Fever 17D Vaccine in Mice
af: Feng Zhu, et al.
Udgivet: (2024-07-01)

Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
af: Nádia Emi Aikawa, et al.
Udgivet: (2022-04-01)

Post-marketing safety surveillance of the rotavirus vaccine in India
af: Gagandeep Kang, et al.
Udgivet: (2023-12-01)

Yellow fever
af: Aluízio Prata
Udgivet: (2000-01-01)

Yellow fever
af: Prata Aluízio
Udgivet: (2000-01-01)

Yellow Fever
af: Marcelo Simão Ferreira
Udgivet: (2019-11-01)

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
af: Lex G. Medina-Magües, et al.
Udgivet: (2023-03-01)

Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys
af: Galler R., et al.
Udgivet: (2005-01-01)

Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial
af: Camacho Luiz Antonio Bastos, et al.
Udgivet: (2004-01-01)

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
af: Juan-Giner, A, et al.
Udgivet: (2021)

The use of reduced doses of the yellow fever vaccine in a sub-Saharan African population: safety, immunogenicity and policy
af: Mbaabu, DK
Udgivet: (2021)

Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV—ANRS 12403
af: Diogo Gama Caetano, et al.
Udgivet: (2024-05-01)

On the Prevention of Yellow Fever
af: article Editorial
Udgivet: (2019-03-01)

The Yellow Fever Fly
af: Hermann August Hagen
Udgivet: (1880-01-01)

Yellow Fever Vaccine
af: Subhash C. Arya
Udgivet: (1999-06-01)

CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
af: Vivian I Avelino-Silva, et al.
Udgivet: (2016-12-01)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
af: Grant A. Mackenzie, et al.
Udgivet: (2022-01-01)

Yellow fever emergency in Liberia

The global burden of yellow fever
af: Katy AM Gaythorpe, et al.
Udgivet: (2021-03-01)

Febre amarela Yellow fever
af: Oswaldo Paulo Forattini
Udgivet: (1999-12-01)

Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials
af: Alexander Domnich, et al.
Udgivet: (2020-06-01)

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial
af: Kulkarni, PS, et al.
Udgivet: (2024)

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
af: Emanuele Montomoli, et al.
Udgivet: (2018-03-01)

Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
af: Kimathi, D, et al.
Udgivet: (2019)

P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen
af: Rice CM, et al.
Udgivet: (2009-10-01)

Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
af: Elena Gianchecchi, et al.
Udgivet: (2023-07-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
af: Alycia P. Fratzke, et al.
Udgivet: (2022-05-01)

Critical appraisal of published research papers – A reinforcing tool for research methodology: Questionnaire-based study
af: Snehalata Gajbhiye, et al.
Udgivet: (2021-01-01)

The global distribution of yellow fever and dengue.
af: Rogers, D, et al.
Udgivet: (2006)

Yellow fever in Putumayo, Colombia, 2024
af: Ivan Camilo Sanchez-Rojas, et al.
Udgivet: (2025-04-01)

Yellow fever – what it means for Singapore
af: Lim, Poh Lian, et al.
Udgivet: (2019)

New diagnostic tools for yellow fever
af: Leong, Wei Yee
Udgivet: (2020)

Yellow Fever: The Challenges Ahead in India
af: Mohan Joshi, et al.
Udgivet: (2012-03-01)

Yellow fever vaccination: The growing demand
af: Himashree Bhattacharyya, et al.
Udgivet: (2024-05-01)